Sign up to save your podcasts
Or
Share Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.9
5656 ratings
Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations.
CME information and select publications here.
More shows like Oncology Today with Dr Neil Love
View all
JAMA Editors' Summary
134 Listeners
NEJM This Week
327 Listeners
JAMA Clinical Reviews
502 Listeners
Breast Cancer Update
67 Listeners
Lung Cancer Update
31 Listeners
Hematologic Oncology Update
77 Listeners
Prostate Cancer Update
15 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gynecologic Oncology Update
12 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
121 Listeners
ASCO Daily News
59 Listeners
The Curbsiders Internal Medicine Podcast
3,377 Listeners
The ONS Podcast
206 Listeners
ASCO Guidelines
48 Listeners
OncLive® On Air
23 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
364 Listeners
Two Onc Docs
197 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
46 Listeners
Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing
0 Listeners